← Evidence map

ReviewThe lancet. Diabetes & endocrinology2025

Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.

Sophie Leboulleux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40318680